Pfizer, Johnson & Johnson Agree To $16.6 Billion Health-care Deal

Health-care products manufacturer Johnson & Johnson has agreed to acquire the consumer health-care products unit of New York-based Pfizer Inc., a manufacturer of consumer, pharmaceutical and animal healthcare products, in a cash deal valued at $16.6 billion.